Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference

BOULDER, Colo., Sept. 6, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2016 Morgan Stanley Global Healthcare Conference in New York City.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.)



Morgan Stanley Global Healthcare Conference


Ron Squarer, Chief Executive Officer


Wednesday, September 14, 2016


8:45 a.m. Eastern Time


About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to


Tricia Haugeto

Array BioPharma Inc.


Logo -


To view the original version on PR Newswire, visit:

SOURCE Array BioPharma